Sign In
Buy AMPH
$19.94
-0.440 (-2.16%)
At Close: Jul 31, 2026
Amphastar Pharmaceuticals: Profitable Pharma With Strong Growth
05:29am, Monday, 20'th May 2024
Amphastar Pharmaceuticals is a small-cap pharmaceutical company focused on developing and selling injectable, inhalation, and intranasal products. The company reported a 29% increase in net revenues i
Patent Peril: 3 Stocks at Risk From the FTC's Drug Crusade
06:15am, Thursday, 16'th May 2024
Several drug stocks are at risk as the Federal Trade Commission is going after pharmaceutical companies that it alleges are trying to keep generic drugs at bay from their branded products. The Biden a
Amphastar Pharmaceuticals, Inc. (AMPH) Q1 2024 Earnings Call Transcript
11:11pm, Wednesday, 08'th May 2024
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH ) Q1 2024 Earnings Conference Call May 8, 2024 5:00 PM ET Company Participants Dan Dischner - Senior Vice President of Corporate Communications William Pet
Amphastar Pharmaceuticals (AMPH) Tops Q1 Earnings and Revenue Estimates
06:16pm, Wednesday, 08'th May 2024
Amphastar Pharmaceuticals (AMPH) came out with quarterly earnings of $1.04 per share, beating the Zacks Consensus Estimate of $0.77 per share. This compares to earnings of $0.62 per share a year ago.
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2024
04:05pm, Wednesday, 08'th May 2024
Reports Net Revenues of $171.8 Million for the Three Months Ended March 31, 2024 RANCHO CUCAMONGA, CA / ACCESSWIRE / May 8, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Co
Amphastar Pharmaceuticals (AMPH) Reports Next Week: Wall Street Expects Earnings Growth
11:07am, Wednesday, 01'st May 2024
Amphastar (AMPH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 8, 2024
04:05pm, Tuesday, 30'th Apr 2024
RANCHO CUCAMONGA, CA / ACCESSWIRE / April 30, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its first quarter of 2024 ended March 31, 2024, a
Why Amphastar (AMPH) Could Beat Earnings Estimates Again
01:11pm, Tuesday, 30'th Apr 2024
Amphastar (AMPH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
New Strong Sell Stocks for April 26th
07:46am, Friday, 26'th Apr 2024
AMPH, BCML and DHC have been added to the Zacks Rank #5 (Strong Sell) List on April 26, 2024.
Amphastar Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference
06:00am, Monday, 01'st Apr 2024
RANCHO CUCAMONGA, CA / ACCESSWIRE / April 1, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, Tony Marrs, EVP of Regulatory Affairs and Clinical Operations,
Is Amphastar (AMPH) a Buy as Wall Street Analysts Look Optimistic?
10:31am, Wednesday, 27'th Mar 2024
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employe
Amphastar Pharmaceuticals (AMPH) Registers a Bigger Fall Than the Market: Important Facts to Note
06:56pm, Tuesday, 26'th Mar 2024
The latest trading day saw Amphastar Pharmaceuticals (AMPH) settling at $43.21, representing a -0.96% change from its previous close.
New Strong Sell Stocks for March 18th
10:15am, Monday, 18'th Mar 2024
ACNB, AMPH and TRDA have been added to the Zacks Rank #5 (Strong Sell) List on March 18, 2024.
Brokers Suggest Investing in Amphastar (AMPH): Read This Before Placing a Bet
10:31am, Monday, 11'th Mar 2024
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employe
Amphastar Pharmaceuticals to Present at the Barclays 26th Annual Global Healthcare Conference
04:05pm, Wednesday, 06'th Mar 2024
RANCHO CUCAMONGA, CA / ACCESSWIRE / March 6, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Tony Marrs, EVP of Regulatory Affairs and Clinical Operation
